{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:13:34Z","timestamp":1784740414740,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFD0501102"],"award-info":[{"award-number":["2017YFD0501102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10753-020-01327-5","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T08:02:42Z","timestamp":1603526562000},"page":"249-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["FGF21 Enhances Therapeutic Efficacy and Reduces Side Effects of Dexamethasone in Treatment of Rheumatoid Arthritis"],"prefix":"10.1007","volume":"44","author":[{"given":"Xu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-zhuo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-hui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4509-738X","authenticated-orcid":false,"given":"De-shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,24]]},"reference":[{"key":"1327_CR1","doi-asserted-by":"crossref","unstructured":"Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356\u2013361.","DOI":"10.1038\/nature01661"},{"key":"1327_CR2","doi-asserted-by":"crossref","unstructured":"Czock, D., F. Keller, F.M. Rasche, and U. Haussler. 2005. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44: 61\u201398.","DOI":"10.2165\/00003088-200544010-00003"},{"key":"1327_CR3","doi-asserted-by":"crossref","unstructured":"Barnes, P.J., and I.M. Adcock. 2009. Glucocorticoid resistance in inflammatory diseases. Lancet 373: 1905\u20131917.","DOI":"10.1016\/S0140-6736(09)60326-3"},{"key":"1327_CR4","doi-asserted-by":"crossref","unstructured":"Kraaij, M.D., S.W. van der Kooij, M.E.J. Reinders, K. Koekkoek, T.J. Rabelink, C. van Kooten, and K.A. Gelderman. 2011. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol Immunol 49: 549\u2013557.","DOI":"10.1016\/j.molimm.2011.10.002"},{"key":"1327_CR5","doi-asserted-by":"crossref","unstructured":"Bernal-Mizrachi, C., S. Weng, C. Feng, B.N. Finck, R.H. Knutsen, T.C. Leone, T.Y. Coleman, R.P. Mecham, D.P. Kelly, and C.F. Semenkovich. 2003. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 9: 1069\u20131075.","DOI":"10.1038\/nm898"},{"key":"1327_CR6","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1186\/ar4684","volume":"16","author":"RH Straub","year":"2014","unstructured":"Straub, R.H. 2014. Rheumatoid arthritis - a neuroendocrine immune disorder: glucocorticoid resistance, relative glucocorticoid deficiency, low-dose glucocorticoid therapy, and insulin resistance. Arthritis Res Ther 16: I1.","journal-title":"Arthritis Res Ther"},{"key":"1327_CR7","doi-asserted-by":"crossref","unstructured":"Mammi, C., V. Marzolla, A. Armani, A. Feraco, A. Antelmi, E. Maslak, S. Chlopicki, F. Cinti, H. Hunt, A. Fabbri, and M. Caprio. 2016. A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet. Int J Obes 40: 964\u2013972.","DOI":"10.1038\/ijo.2016.13"},{"key":"1327_CR8","doi-asserted-by":"crossref","unstructured":"Houstis, N., E.D. Rosen, and E.S. Lander. 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944\u2013948.","DOI":"10.1038\/nature04634"},{"key":"1327_CR9","doi-asserted-by":"crossref","unstructured":"Asrih, M., and F.R. Jornayvaz. 2013. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 218: R25\u9225\u63dc36.","DOI":"10.1530\/JOE-13-0201"},{"key":"1327_CR10","doi-asserted-by":"crossref","unstructured":"Fisher, F.M., and E. Maratos-Flier. 2016. Understanding the physiology of FGF21. Ann Rev Physiol 78: 223\u2013241.","DOI":"10.1146\/annurev-physiol-021115-105339"},{"key":"1327_CR11","doi-asserted-by":"crossref","unstructured":"Babaknejad, N., H. Nayeri, R. Hemmati, S. Bahrami, and A. Esmaillzadeh. 2018. An overview of FGF19 and FGF21: the therapeutic role in the treatment of the metabolic disorders and obesity. Horm Metab Res 50: 441\u2013452.","DOI":"10.1055\/a-0623-2909"},{"key":"1327_CR12","doi-asserted-by":"crossref","unstructured":"Kim, K.H., Y.T. Jeong, H. Oh, S.H. Kim, J.M. Cho, Y.N. Kim, S.S. Kim, D.H. Kim, K.Y. Hur, H.K. Kim, T.H. Ko, J. Han, H.L. Kim, J. Kim, S.H. Back, M. Komatsu, H. Chen, D.C. Chan, M. Konishi, N. Itoh, C.S. Choi, and M.S. Lee. 2013. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med 19: 83\u201392.","DOI":"10.1038\/nm.3014"},{"key":"1327_CR13","doi-asserted-by":"crossref","unstructured":"Coskun, T., H.A. Bina, M.A. Schneider, J.D. Dunbar, C.C. Hu, Y.Y. Chen, D.E. Moller, and A. Kharitonenkov. 2008. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149: 6018\u20136027.","DOI":"10.1210\/en.2008-0816"},{"key":"1327_CR14","doi-asserted-by":"crossref","unstructured":"Yu, Y., S. Li, Y. Liu, G. Tian, Q. Yuan, F. Bai, W. Wang, Z. Zhang, G. Ren, Y. Zhang, and D. Li. 2015. Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway. Int Immunopharmacol 25: 74\u201382.","DOI":"10.1016\/j.intimp.2015.01.005"},{"key":"1327_CR15","doi-asserted-by":"crossref","unstructured":"Walsh, N.C., T.N. Crotti, S.R. Goldring, and E.M. Gravallese. 2005. Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 208: 228\u2013251.","DOI":"10.1111\/j.0105-2896.2005.00338.x"},{"key":"1327_CR16","doi-asserted-by":"crossref","unstructured":"Muller-Ladner, U., T. Pap, R.E. Gay, M. Neidhart, and S. Gay. 2005. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 1: 102\u2013110.","DOI":"10.1038\/ncprheum0047"},{"key":"1327_CR17","doi-asserted-by":"crossref","unstructured":"Jiang, X., M. Zhao, Y. Wang, H. Zhu, S. Zhao, J. Wu, Y. Song, and S. Peng. 2016. RGD(F\/S\/V)-Dex: towards the development of novel, effective, and safe glucocorticoids. Drug Des Dev Ther 10: 1059\u20131076.","DOI":"10.2147\/DDDT.S99568"},{"key":"1327_CR18","doi-asserted-by":"crossref","unstructured":"Ren, H., D. Liang, X. Jiang, J. Tang, J. Cui, Q. Wei, S. Zhang, Z. Yao, G. Shen, and S. Lin. 2015. Variance of spinal osteoporosis induced by dexamethasone and methylprednisolone and its associated mechanism. Steroids 102: 65\u201375.","DOI":"10.1016\/j.steroids.2015.07.006"},{"key":"1327_CR19","doi-asserted-by":"crossref","unstructured":"Chopra, A., M. Saluja, T. Kianifard, D. Chitre, and A. Venugopalan. 2018. Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis. J Ayurveda Integr Med 9: 201\u2013208.","DOI":"10.1016\/j.jaim.2017.07.009"},{"key":"1327_CR20","doi-asserted-by":"crossref","unstructured":"van Schouwenburg, P.A., C.L. Krieckaert, M. Nurmohamed, M. Hart, T. Rispens, L. Aarden, D. Wouters, and G.J. Wolbink. 2012. IgG4 production against adalimumab during long term treatment of RA patients. J Clin Immunol 32: 1000\u20131006.","DOI":"10.1007\/s10875-012-9705-0"},{"key":"1327_CR21","doi-asserted-by":"crossref","unstructured":"Orbak, Z. 2006. Glucocorticoid resistance. Biochemistry (Mosc) 71: 1073\u20131081.","DOI":"10.1134\/S0006297906100038"},{"key":"1327_CR22","doi-asserted-by":"crossref","unstructured":"Li, H.T., J. Zhang, and W.P. Jia. 2013. Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology. Front Med 7: 25\u201330.","DOI":"10.1007\/s11684-013-0244-8"},{"key":"1327_CR23","doi-asserted-by":"crossref","unstructured":"Xu, J., D.J. Lloyd, C. Hale, S. Stanislaus, M. Chen, G. Sivits, S. Vonderfecht, R. Hecht, Y.S. Li, R.A. Lindberg, J.L. Chen, D. Young Jung, Z. Zhang, H.J. Ko, J.K. Kim, and M.M. Veniant. 2009. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58: 250\u2013259.","DOI":"10.2337\/db08-0392"},{"key":"1327_CR24","doi-asserted-by":"crossref","unstructured":"Su, X., Y. Kong, and D.Q. Peng. 2019. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. Clin Chim Acta 498: 30\u201337.","DOI":"10.1016\/j.cca.2019.08.005"},{"key":"1327_CR25","doi-asserted-by":"crossref","unstructured":"Luan, G.X., G. Li, X. Ma, Y.C. Jin, N. Hu, J. Li, Z.H. Wang, and H.L. Wang. 2019. Dexamethasone-induced mitochondrial dysfunction and insulin resistance-study in 3t3-l1 adipocytes and mitochondria isolated from mouse liver. Molecules 24.","DOI":"10.3390\/molecules24101982"},{"key":"1327_CR26","doi-asserted-by":"crossref","unstructured":"Yuen, K.C., L.E. Chong, and M.C. Riddle. 2013. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans. Diabet Med 30: 651\u2013663.","DOI":"10.1111\/dme.12184"},{"key":"1327_CR27","doi-asserted-by":"crossref","unstructured":"Seckl, J.R., N.M. Morton, K.E. Chapman, and B.R. Walker. 2004. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 59: 359\u2013393.","DOI":"10.1210\/rp.59.1.359"},{"key":"1327_CR28","doi-asserted-by":"crossref","unstructured":"Pichardo-Lowden, A., and A. Manni. 2010. Cushing syndrome related to gingival application of a dexamethasone-containing preparation. Endocr Pract 16: 336\u2013336.","DOI":"10.2165\/00128415-201013130-00056"},{"key":"1327_CR29","doi-asserted-by":"crossref","unstructured":"Hochberg, I., I. Harvey, Q.T. Tran, E.J. Stephenson, A.L. Barkan, A.R. Saltiel, W.F. Chandler, and D. Bridges. 2015. Gene expression changes in subcutaneous adipose tissue due to Cushing's disease. J Mol Endocrinol 55: 81\u201394.","DOI":"10.1530\/JME-15-0119"},{"key":"1327_CR30","doi-asserted-by":"crossref","unstructured":"Arnaldi, G., A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, and M. Boscaro. 2003. Diagnosis and complications of Cushing\u9225\u6a9a syndrome: a consensus statement. J Clin Endocrinol Metab 88: 5593\u20135602.","DOI":"10.1210\/jc.2003-030871"},{"key":"1327_CR31","doi-asserted-by":"crossref","unstructured":"Raffaele, M., L. Bellner, S.P. Singh, G. Favero, R. Rezzani, L.F. Rodella, J.R. Falck, N.G. Abraham, and L. Vanella. 2019. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1 alpha-HO-1-PGC1 alpha-mitochondrial signaling. Exp Cell Res 380: 180\u2013187.","DOI":"10.1016\/j.yexcr.2019.04.029"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-020-01327-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T10:14:49Z","timestamp":1635243289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-020-01327-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,24]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1007\/s10753-020-01327-5","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,24]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}